Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05897710 · ClinicalTrials.gov registry record · NA
Virtual World-Based Cardiac Rehabilitation
A NA study of Cardiovascular Diseases and Telemedicine, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,881
- Enrollment target
- 1
- Study location
NCT05897710: Completed NA study of Cardiovascular Diseases and Telemedicine, sponsored by Mayo Clinic.
NCT05897710 is a NA study of Cardiovascular Diseases and Telemedicine that has completed, run by Mayo Clinic. The registered enrollment target is 2,881 participants, below the 26,965-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05897710, a NA study of Cardiovascular Diseases and Telemedicine, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,881 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and adherence of "Destination Cardiac Rehab" compared to traditional center-based CR.
Primary Outcome
Changes from baseline in healthy diet using the Mediterranean Eating Patterns for Americans (MEPA), a 16-item questionnaire evaluating accordance with a Mediterranean-like diet pattern
Conditions Studied
Interventions
- OTHER Virtual World-Based Cardiac Rehabilitation (VWCR)
- OTHER Center-Based Cardiac Rehabilitation (CBCR)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,881 participants |
| Start Date | 2023-03-07 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
What the finished NCT05897710 record still lists
NCT05897710 is an interventional study that assigns participants to a tested intervention. Its 2,881 participants enrollment target places it among the larger protocols in the corpus, below the 26,965-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Virtual World-Based Cardiac Rehabilitation (VWCR) is the first listed.
NCT05897710 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05897710 about?
NCT05897710 is a clinical study titled "Virtual World-Based Cardiac Rehabilitation". The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and a...
What is the current status of trial NCT05897710?
This trial is currently completed. It is a NA study. The enrollment target is 2,881 participants. The study started on 2023-03-07. Estimated completion is 2024-01-31.
What conditions does trial NCT05897710 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Telemedicine, Cardiac Event.
What interventions are being tested in trial NCT05897710?
The interventions under investigation include: Virtual World-Based Cardiac Rehabilitation (VWCR) (OTHER), Center-Based Cardiac Rehabilitation (CBCR) (OTHER).
Who is sponsoring clinical trial NCT05897710?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05897710 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05897710's enrollment target sits among peer trials
2,881 30th of 300 higher than 271 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- NCT06351085 · 2,869 participants · NA
Enhancing Lung Cancer Screening Through Human-Centered Intervention
- NCT06273436 · 2,894 participants · NA
Healing, Equity, Advocacy and Respect for Mamas
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI